威尔药业
(603351)
| 流通市值：33.45亿 | | | 总市值：33.45亿 |
| 流通股本：1.35亿 | | | 总股本：1.35亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 169,866,020.06 | 173,214,813 | 146,935,955.31 | 157,546,346.64 |
| 应收票据及应收账款 | 193,302,097.11 | 241,249,914.37 | 205,586,385.45 | 187,897,336.4 |
| 应收账款 | 193,302,097.11 | 241,249,914.37 | 205,586,385.45 | 187,897,336.4 |
| 应收款项融资 | 50,857,741.82 | 44,876,923.34 | 47,498,994.17 | 52,118,633.48 |
| 预付款项 | 25,669,470.84 | 21,891,705.48 | 24,833,653.33 | 18,278,045.19 |
| 其他应收款合计 | 2,659,106.45 | 2,585,858.11 | 3,728,357.73 | 4,900,376.55 |
| 存货 | 152,327,215.97 | 166,702,691.22 | 189,320,620.75 | 170,577,369.32 |
| 其他流动资产 | 4,534,914.97 | 5,092,797.36 | 7,106,114.77 | 6,850,983.33 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 599,216,567.22 | 655,614,702.88 | 626,214,281.51 | 599,420,990.91 |
| 非流动资产: | | | | |
| 其他非流动金融资产 | 83,412,979.02 | 83,412,979.02 | 71,292,317.89 | 71,292,317.89 |
| 固定资产 | 1,321,587,101.92 | 1,199,768,026.85 | 956,090,091.19 | 976,963,182.38 |
| 在建工程 | 119,038,753.02 | 256,434,223.75 | 500,394,465.56 | 494,949,300.06 |
| 使用权资产 | 20,551,748.11 | 22,726,484.7 | 24,901,221.29 | 27,075,957.88 |
| 无形资产 | 112,795,339.13 | 113,998,190.49 | 97,286,754 | 98,371,913.94 |
| 长期待摊费用 | 317,053.76 | 325,461.89 | 332,947.68 | 348,866.58 |
| 递延所得税资产 | 10,741,701.91 | 8,192,973.1 | 8,955,566.47 | 9,250,413.35 |
| 其他非流动资产 | 11,776,165.44 | 4,905,321.27 | 2,694,180.87 | 1,229,716.41 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 1,680,220,842.31 | 1,689,763,661.07 | 1,661,947,544.95 | 1,679,481,668.49 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 2,279,437,409.53 | 2,345,378,363.95 | 2,288,161,826.46 | 2,278,902,659.4 |
| 流动负债: | | | | |
| 短期借款 | 331,185,736.11 | 403,607,708.33 | 344,456,852.78 | 362,221,219.44 |
| 应付票据及应付账款 | 84,441,407.51 | 102,526,684.66 | 112,685,426.63 | 105,824,474.56 |
| 应付账款 | 84,441,407.51 | 102,526,684.66 | 112,685,426.63 | 105,824,474.56 |
| 合同负债 | 10,387,871.14 | 9,391,336.91 | 11,962,847.4 | 7,983,346.71 |
| 应付职工薪酬 | 15,809,452.1 | 13,796,365.48 | 8,825,705.27 | 25,429,837.09 |
| 应交税费 | 9,541,598.08 | 13,194,240.61 | 15,513,028.83 | 13,322,644.74 |
| 其他应付款合计 | 15,160,570.68 | 26,833,435.02 | 22,973,956.92 | 21,256,176.74 |
| 一年内到期的非流动负债 | 48,181,185.17 | 47,444,221.6 | 15,623,994.74 | 20,672,519.57 |
| 其他流动负债 | 1,346,380.05 | 1,220,873.79 | 1,555,038.08 | 1,037,835.07 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 516,054,200.84 | 618,014,866.4 | 533,596,850.65 | 557,748,053.92 |
| 非流动负债: | | | | |
| 长期借款 | 44,500,000 | 52,500,000 | 86,300,000 | 85,300,000 |
| 租赁负债 | 15,074,244.9 | 15,932,385.13 | 16,128,219.88 | 18,764,214.89 |
| 递延收益 | 13,163,081.64 | 13,296,031.65 | 12,866,256.65 | 12,710,681.65 |
| 递延所得税负债 | 14,809,597.91 | 14,579,765.75 | 11,700,101.94 | 11,698,617.61 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 87,546,924.45 | 96,308,182.53 | 126,994,578.47 | 128,473,514.15 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 603,601,125.29 | 714,323,048.93 | 660,591,429.12 | 686,221,568.07 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 135,439,132 | 135,439,132 | 135,439,132 | 135,439,132 |
| 资本公积 | 942,901,810.78 | 942,370,834.53 | 941,661,674.1 | 941,355,105.34 |
| 减:库存股 | - | 12,788,419.2 | 12,788,419.2 | 12,788,419.2 |
| 专项储备 | 1,977,286.93 | 3,833,649.07 | 3,855,290.89 | 2,788,985.85 |
| 盈余公积 | 60,958,614.65 | 60,958,614.65 | 60,958,614.65 | 60,958,614.65 |
| 未分配利润 | 528,935,171.78 | 494,933,115.79 | 491,273,160.16 | 456,669,614.74 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,670,212,016.14 | 1,624,746,926.84 | 1,620,399,452.6 | 1,584,423,033.38 |
| 少数股东权益 | 5,624,268.1 | 6,308,388.18 | 7,170,944.74 | 8,258,057.95 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 1,675,836,284.24 | 1,631,055,315.02 | 1,627,570,397.34 | 1,592,681,091.33 |
| 负债和股东权益合计 | 2,279,437,409.53 | 2,345,378,363.95 | 2,288,161,826.46 | 2,278,902,659.4 |
| 公告日期 | 2024-10-24 | 2024-08-20 | 2024-04-26 | 2024-04-26 |
| 审计意见(境内) | | | | 标准无保留意见 |